Head-to-head · WeighScore
Eloria vs NowPatient
The verdict
NowPatient takes it — 65.5/100 to 65.4/100, but only just.
NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Eloria is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eloria | NowPatient |
|---|---|---|
| WeighScore | 65.4/100 | 65.5/100 |
| Grade | C | C |
| Scorecard rank | #224 | #222 |
| Semaglutide | $179/mo (starting dose, plus a separate fee, compounded) | $1,349/mo (brand Wegovy) |
| Tirzepatide | Not disclosed | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #224 · C
Strengths
- Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
- Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
- Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
- HSA/FSA accepted, free shipping on every order, and 24/7 support
- Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)
Where it loses points
- Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
- State availability varies and is not published - only where providers are licensed and pharmacies can dispense
- The compounding pharmacy partner is not named (US-licensed pharmacies only)
- No LegitScript certification displayed
- Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
Graded #222 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.